AI Article Synopsis
- Cardiac rhabdomyomas are frequently found in patients with tuberous sclerosis, a genetic disorder.
- A case is presented where a child experienced arrhythmia due to rhabdomyoma that did not respond to standard antiarrhythmic medications.
- The arrhythmia was successfully treated with the mTOR inhibitor sirolimus, marking the first known use of this drug for this type of condition.
Article Abstract
Cardiac rhabdomyomas are common in tuberous sclerosis. We report a child who developed rhabdomyoma related arrhythmia refractory to antiarrhythmic drug therapy. Reversion of the atrial ectopic tachycardia was achieved with mammalian target of rapamycin pathway (mTOR) inhibitor sirolimus. As per our knowledge, this is the first time that sirolimus has been successfully used in this setting.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6931800 | PMC |
| http://dx.doi.org/10.1111/anec.12435 | DOI Listing |
Publication Analysis
Top Keywords
atrial ectopic
8
ectopic tachycardia
8
successful sirolimus
4
sirolimus refractory
4
refractory atrial
4
tachycardia child
4
child cardiac
4
cardiac rhabdomyoma
4
rhabdomyoma cardiac
4
cardiac rhabdomyomas
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!